Analgesics (Pharmacies) - Italy | Statista Market Forecast

Revenue in the Analgesics market is projected to reach US$653.30m in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 3.55%, resulting in a market volume of US$777.80m by 2029.
In global comparison, most revenue will be generated China (US$5.03bn in 2024).
In relation to total population figures, per person revenues of US$11.13 are generated in 2024.

Definition:
The Analgesics market encompasses non-prescription natural and synthetic non-opioid analgesics sold through pharmacies. These include well-known products such as Paracetamol, Ibuprofen, Aspirin, Diclofenac, and various pain-relieving preparations. The market's scope varies with national legislation concerning opioid analgesics, with legal opioids being incorporated based on respective state regulations. In countries like Germany, Austria, and Switzerland, opioid analgesics are included if they comply with narcotics law limitations and do not necessitate a prescription. The analgesics are presented in forms like pills, capsules, gels, and ointments. However, the market excludes prescription medications (e.g., morphine), anesthetics, and homeopathic remedies. Notable top-selling painkillers encompass Voltaren, Aspirin, Thomapyrin, Ibuprofen, Dolormin, Paracetamol, and ASS. This market exclusively covers product sales through pharmacies.

Additional information:
The Analgesics market comprises revenues, average revenue per capita and average revenue per pharmacy. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.

Over-the-counter analgesics (e.g. Aspirin and Paracetamol)
Natural and synthetic agents
In the form of pills, capsules, gels and ointments

Prescription medicines
Homeopathic remedies
Anesthetics

The Analgesics (Pharmacies) market in Italy is experiencing steady growth due to changing customer preferences, emerging trends in the market, and local special circumstances.

Customer preferences: Italian customers are increasingly seeking over-the-counter analgesics from pharmacies for their pain relief needs. This shift in preference can be attributed to the convenience of purchasing these products directly from pharmacies, where trained professionals can provide guidance and recommendations. Furthermore, customers value the wide range of analgesic options available in pharmacies, allowing them to choose products that best suit their individual needs.

Trends in the market: One notable trend in the Analgesics (Pharmacies) market in Italy is the growing demand for natural and herbal analgesics. Customers are becoming more conscious of the ingredients used in their pain relief products and are opting for natural alternatives. This trend aligns with the overall shift towards natural and holistic healthcare products and reflects a desire for more sustainable and environmentally-friendly options. Pharmacies are responding to this trend by expanding their range of natural analgesics and promoting their benefits to customers. Another trend in the market is the increasing use of online platforms for purchasing analgesics. Customers are appreciating the convenience of online shopping, which allows them to compare prices and products from the comfort of their own homes. This trend has prompted pharmacies to establish online platforms and offer home delivery services, catering to the evolving needs and preferences of their customers.

Local special circumstances: Italy has a well-established pharmacy network, with pharmacies playing a crucial role in the healthcare system. Customers have a strong trust in pharmacists and rely on their expertise when it comes to selecting the right analgesic products. This trust and reliance on pharmacists create a unique market dynamic, where pharmacies are seen as the go-to source for analgesics.

Underlying macroeconomic factors: The growing Analgesics (Pharmacies) market in Italy can also be attributed to favorable macroeconomic factors. Italy has a high prevalence of chronic pain conditions, such as arthritis and back pain, which drive the demand for analgesics. Additionally, the aging population in Italy contributes to the increasing demand for pain relief products. As the population ages, the need for analgesics is expected to continue growing, further fueling the market. In conclusion, the Analgesics (Pharmacies) market in Italy is developing due to changing customer preferences, emerging trends, local special circumstances, and underlying macroeconomic factors. The shift towards natural and herbal analgesics, the increasing use of online platforms for purchasing, the trust in pharmacists, and the prevalence of chronic pain conditions contribute to the growth of the market. With these factors in play, the market is expected to continue expanding in the coming years.

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

The global online pharmacy sector was estimated at 32 billion U.S. dollars by the end of 2023. In the United States, forecasts indicate that this figure would reach approximately 5.7 billion, solidifying its position as one of the largest online pharmacy markets. However, China dominates the pharma e-commerce industry worldwide, generating nearly 8.5 billion dollars in revenue. With China at the forefront, it is no wonder digital pharmacies make up the fastest-growing segment in the Asian digital health market.